Department of Neurosurgery, West Division of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430056, China.
Department of Neurosurgery, West Division of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430056, China.
FEBS Lett. 2014 Jan 3;588(1):192-7. doi: 10.1016/j.febslet.2013.11.036. Epub 2013 Dec 6.
MicroRNAs (miRNAs) act as key regulators of multiple cancers. miR-329 functions as a tumor suppressor in some malignancies. However, its role in neuroblastoma remains poorly understood. We found that miR-329 was decreased in metastatic tumor tissues compared with matched primary tumor tissues. Forced overexpression of miR-329 substantially suppressed cell proliferation, colony formation, migration, and invasion of neuroblastoma cells. Lysine-specific demethylase 1 (KDM1A) was found to be a target of miR-329. Furthermore, down-regulation of KDM1A by shRNA performed similar effects with overexpression of miR-329. Overexpression of KDM1A partially reversed the tumor suppressive effects of miR-329 in neuroblastoma cells. Collectively, miR-329 may suppress neuroblastoma cell growth and motility partially by targeting KDM1A.
MicroRNAs (miRNAs) 作为多种癌症的关键调节因子发挥作用。miR-329 在一些恶性肿瘤中作为肿瘤抑制因子发挥作用。然而,其在神经母细胞瘤中的作用仍知之甚少。我们发现,转移性肿瘤组织中的 miR-329 水平低于配对的原发性肿瘤组织。过表达 miR-329 可显著抑制神经母细胞瘤细胞的增殖、集落形成、迁移和侵袭。赖氨酸特异性去甲基酶 1(KDM1A)被发现是 miR-329 的靶标。此外,shRNA 下调 KDM1A 的作用与过表达 miR-329 相似。过表达 KDM1A 部分逆转了 miR-329 在神经母细胞瘤细胞中的肿瘤抑制作用。总之,miR-329 可能通过靶向 KDM1A 部分抑制神经母细胞瘤细胞的生长和迁移。